Study guide
7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels
CIH Certified Industrial Hygienist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The CIH Exam and How to Use This Guide
1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan
2 Chapter 2: Basic Science & Calculations
2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals
3 Chapter 3: Air Sampling & Instrumentation
3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration
4 Chapter 4: Analytical Chemistry & Lab Methods
4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency
5 Chapter 5: Biostatistics & Epidemiology
5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection
6 Chapter 6: Toxicology & Biological Monitoring
6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring
7 Chapter 7: Biohazards & Indoor Environmental Quality
7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs
8 Chapter 8: Community Exposure & Environmental Health
8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know
9 Chapter 9: Health Risk Analysis & Hazard Communication
9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties
10 Chapter 10: Industrial Ventilation Principles & LEV Design
10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections
11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics
11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing
12 Chapter 12: Noise Measurement & Hearing Conservation
12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration
13 Chapter 13: Thermal Stress Assessment & Control
13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill
14 Chapter 14: Ionizing Radiation Protection
14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys
15 Chapter 15: Non-Ionizing Radiation & Laser Safety
15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance
16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment
16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control
17 Chapter 17: Ergonomics & Workstation Design
17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics
18 Chapter 18: Work Environments & Industrial Processes
18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation
19 Chapter 19: IH Program Management & Professional Ethics
19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement
7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels
Key Takeaways Explain This Topic AI
The CDC/NIH BMBL manual establishes four Biosafety Levels (BSL-1 to BSL-4); BSL-3 requires controlled access, inward directional airflow (negative pressure), and dedicated HEPA-filtered exhaust for aerosol-transmitted pathogens like Mycobacterium tuberculosis and SARS-CoV-2.
Biosafety Cabinets (BSCs) provide distinct protection profiles: Class I protects worker and environment only (no product protection); Class II Type A2 recirculates 70% and exhausts 30% HEPA-filtered air with negative pressure plenums; Class II Type B2 requires 100% total hard-ducted exhaust (0% recirculation) for work involving volatile toxic chemicals or radionuclides alongside biological agents.
OSHA Bloodborne Pathogens standard (29 CFR 1910.1030) mandates a written Exposure Control Plan, Universal Precautions, engineering sharps controls, free Hepatitis B vaccination within 10 working days of assignment, and post-exposure prophylaxis (PEP) protocols.
Legionella pneumophila multiplies in water systems between 20°C and 50°C (optimal 35°C-46°C); prevention under ASHRAE Standard 188 requires hot water storage at ≥ 60°C (140°F) and secondary distribution at ≥ 50°C (122°F) to prevent Legionnaires' disease (severe pneumonia) and Pontiac fever.
Endotoxins (lipopolysaccharide / LPS lipid A complexes from Gram-negative bacterial cell walls) cause acute non-allergic macrophage activation; measured via the Limulus Amebocyte Lysate (LAL) assay in Endotoxin Units (EU), where ACGIH guidelines recommend limiting airborne exposure below 90 EU/m³.
Last updated: August 2026
Infectious Agents, Bloodborne Pathogens, and Biosafety Levels
Industrial hygienists working in healthcare, biomedical research, pharmaceutical manufacturing, agricultural facilities, and municipal water management must evaluate and control occupational hazards arising from infectious biological agents. This requires mastering regulatory standards such as OSHA's Bloodborne Pathogens standard, institutional biosafety frameworks governed by the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), the fluid dynamics of Biosafety Cabinets (BSCs), and the environmental control of waterborne pathogens like Legionella pneumophila .
1. CDC/NIH Biosafety Levels (BSL-1 to BSL-4)
The CDC and NIH define four progressive Biosafety Levels (BSLs) that combine laboratory practices, safety equipment (primary barriers), and facility design (secondary barriers) based on pathogen risk assessments. ┌──────────────────────────────────────────────────────────┐
- │ Biosafety Level (BSL) Hierarchy │
- └────────────────────────────┬─────────────────────────────┘
- │
- ┌─────────────────┬───────────────┴───────────────┬─────────────────┐
- ▼ ▼ ▼ ▼
- ┌───────┐ ┌───────┐ ┌───────┐ ┌───────┐
- │ BSL-1 │ │ BSL-2 │ │ BSL-3 │ │ BSL-4 │
- └───────┘ └───────┘ └───────┘ └───────┘
- Low Risk Moderate Risk High Risk Extreme Risk
- Non-pathogenic Indigenous agents Aerosol trans. Exotic/Lethal
- Open bench Biohazard warning Negative air Pos-pressure suit
- e.g., E. coli K12 e.g., HBV, Salmonella e.g., M. tb, SARS e.g., Ebola
- Detailed BSL Characteristics
Biosafety Level Pathogen Risk & Transmission Route Representative Biological Agents Primary Containment Barriers & Safety Equipment Secondary Containment & Facility Architecture
BSL-1 Well-characterized agents not known to consistently cause disease in immunocompetent adult humans; minimal individual and community risk. Bacillus subtilis , non-pathogenic Escherichia coli (e.g., K-12 strain), Saccharomyces cerevisiae . Standard open laboratory bench work; standard personal protective equipment (PPE): lab coat, gloves, eye protection. Standard sink for handwashing; easily cleanable, non-porous work surfaces; doors to separate work areas.
BSL-2 Moderate-risk indigenous agents associated with human disease of varying severity; transmitted via percutaneous injury, ingestion, or mucous membrane exposure. Hepatitis B Virus ( HBV ), Hepatitis C Virus ( HCV ), Human Immunodeficiency Virus ( HIV ), Salmonella spp., Staphylococcus aureus (MRSA). Class II Biosafety Cabinets (BSCs) used whenever aerosol-generating procedures (centrifugation, vortexing, sonicating) occur; biohazard warning signs; autoclave for waste decontamination. Self-closing, lockable doors; eyewash station readily accessible; biohazard waste management protocols; restricted laboratory access.
BSL-3 Indigenous or exotic agents with potential for aerosol transmission ; causes serious, potentially lethal infection with known therapeutic or vaccine interventions. Mycobacterium tuberculosis , Bacillus anthracis , Yersinia pestis , SARS-CoV-2 , Coccidioides immitis , Yellow Fever virus. All procedures conducted within Class II or Class III BSCs ; certified respiratory protection (PAPR or elastomeric N95/P100); protective laboratory clothing (solid-front gowns, double gloves). Directional inward airflow (negative pressure) with no recirculation to non-BSL-3 areas; double-door access anteroom; sealed penetrations; all exhaust air HEPA-filtered or discharged through high-plume stacks.
BSL-4 Dangerous and exotic agents with high individual risk of aerosol-transmitted life-threatening disease; frequently lack vaccines, prophylaxis, or specific antiviral treatments. Ebola virus , Marburg virus, Lassa virus, Crimean-Congo hemorrhagic fever, Smallpox ( Variola virus). All work performed in Class III BSCs (glove box) OR in full-body, positive-pressure air-supplied suits connected to dedicated breathing air systems. Isolated dedicated building or completely sealed containment zone; dedicated supply and double-HEPA exhaust filtration systems; continuous negative pressure; pass-through dunk tanks and autoclaves; chemical shower.
2. Biosafety Cabinets (BSCs) and Engineering Containment
Biosafety cabinets provide primary containment for biological agents through directed airflow and High-Efficiency Particulate Air ( HEPA ) filtration. HEPA filters capture ≥ 99.97% of particles down to 0.3µm (the Most Penetrating Particle Size, MPPS).
Crucial Distinction: A Laminar Flow Clean Bench blows HEPA-filtered air outward across the work surface directly toward the worker's face. It provides product protection only and must NEVER be used with infectious agents, chemicals, or allergens!
- Biosafety Cabinet Classification Matrix ┌─────────────────────────────┐
- │ Biosafety Cabinets (Class II)│
- └──────────────┬──────────────┘
- │
- ┌───────────────────────────┴───────────────────────────┐
- ▼ ▼
- ┌───────────────────────────────┐ ┌───────────────────────────────┐
- │ Class II Type A2 │ │ Class II Type B2 │
- ├───────────────────────────────┤ ├───────────────────────────────┤
- │ • 70% Air Recirculated │ │ • 0% Air Recirculated │
- │ • 30% Air HEPA Exhausted │ │ • 100% Total Exhaust │
- │ • Negative Pressure Plenum │ │ • Hard-Ducted to Outdoors │
- │ • Trace/No Volatiles │ │ • Volatile Toxic Chemicals OK │
- └───────────────────────────────┘ └───────────────────────────────┘
BSC Class & Type Inflow Face Velocity Downflow / Recirculation Percentage Exhaust Percentage & Discharge Mechanism Chemical / Volatile Vapor Suitability
Class I ≥ 75 fpm (0.38 m/s) 0% (no downflow laminar air; no product protection ). 100% exhausted through HEPA to room or building exhaust. Protects personnel and environment only; no volatile toxic chemicals unless ducted.
Class II, Type A1 ≥ 75 fpm (0.38 m/s) ~ 70% recirculated via supply HEPA. ~ 30% exhausted via HEPA to room or thimble/canopy. Unsuitable for volatile chemicals ; positive pressure contaminated plenums.
Class II, Type A2 ≥ 100 fpm (0.51 m/s) ~ 70% recirculated via supply HEPA. ~ 30% exhausted via HEPA; negative pressure plenums surround contaminated zones. Suitable for minute/trace quantities of volatile chemicals ONLY if ducted via canopy thimble connection.
Class II, Type B1 ≥ 100 fpm (0.51 m/s) ~ 30% recirculated via supply HEPA. ~ 70% hard-ducted through dedicated exhaust HEPA. Suitable for moderate quantities of volatile toxic chemicals used in rear work zone.
Class II, Type B2 ≥ 100 fpm (0.51 m/s) 0% (Total Exhaust; no recirculation) . 100% hard-ducted through dedicated building exhaust HEPA. Required for work with volatile toxic chemicals, radionuclides, or antineoplastic drugs combined with biologicals.
Class III Gas-tight hermetic box 0% recirculation; total negative pressure (≥ 0.5 in. w.g. ). 100% double-HEPA filtered exhaust; pass-through autoclave. Highest containment (BSL-4); heavy rubber arm-length gloves; gas-tight seal.
NSF/ANSI Standard 49 Certification Testing
Field certification of Class II BSCs is required annually, upon relocation, or after HEPA replacement:
Inflow Velocity Test: Measurement of face velocity across the sash opening using a thermal anemometer or direct inflow measurement (DIM) hood.
Downflow Velocity Profile: Grid measurements of downward laminar air velocities (55-65 fpm).
HEPA Filter Integrity Test: Upstream aerosol challenge with polyalphaolefin (PAO) or dioctyl phthalate (DOP) with downstream photometer scanning (< 0.01% penetration threshold).
Airflow Smoke Pattern Test: Visual verification of containment with no stagnant dead spots or escape eddies at sash boundaries.
3. OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030)
The OSHA standard protects employees with reasonably anticipated occupational exposure to human blood and Other Potentially Infectious Materials (OPIM) .
Scope and OPIM Definitions
Covered OPIM: Semen, vaginal secretions, cerebrospinal fluid (CSF), synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in dental procedures, any body fluid visibly contaminated with blood, and all unfixed human tissues/organs or cell cultures.
Non-Covered Fluids (unless visibly blood-contaminated): Tears, sweat, non-bloody saliva, non-bloody urine, non-bloody feces, and non-bloody vomitus.
Mandatory Regulatory Requirements
Written Exposure Control Plan (ECP): Must be reviewed and updated at least annually and whenever procedures change. Must document worker input on the identification, evaluation, and selection of effective engineering sharps controls (mandated by the Needlestick Safety and Prevention Act).
Universal / Standard Precautions: An infection control approach where all human blood and OPIM are treated as if known to be infectious for HIV, HBV, HCV, and other bloodborne pathogens.
Engineering & Work Practice Controls: Sharps disposal containers (puncture-resistant, leak-proof, labeled/color-coded), needleless IV systems, engineered self-sheathing sharps. Two-handed needle recapping and bending/shearing of contaminated needles is strictly prohibited.
Hepatitis B Vaccination: Must be offered at no cost to all occupationally exposed employees within 10 working days of initial assignment after mandatory training. Employees who decline must sign a standard OSHA declination statement; they may receive the vaccine free of charge at any future date if still exposed.
Post-Exposure Evaluation and Follow-up: Following an exposure incident (e.g., needlestick, splash to mucous membranes):
Immediate confidential medical evaluation and documentation of route of exposure.
Identification and testing of the source individual's blood for HBV, HCV, and HIV (subject to state consent laws).
Collection and baseline serological testing of the exposed employee.
Provision of Post-Exposure Prophylaxis (PEP) according to current CDC guidelines (e.g., antiretroviral therapy initiated ideally within 2 hours for HIV; Hepatitis B Immune Globulin [HBIG] + vaccine series for non-immune individuals).
Written healthcare professional opinion provided to employee within 15 days.
Recordkeeping: Sharps Injury Log maintained per 1910.1030(h)(5); medical records retained for the duration of employment plus 30 years (29 CFR 1910.1020).
4. Legionella pneumophila and Water System Management
Legionella pneumophila is a fastidious, Gram-negative, rod-shaped bacterium ubiquitous in natural freshwater environments that readily colonizes engineered water systems.
Pathophysiology & Clinical Manifestations
Transmission: Inhalation of respirable water aerosols (1-5µm) containing bacteria, or direct micro-aspiration of contaminated potable water. No person-to-person transmission occurs.
Legionnaires' Disease: Severe multisystem pneumonia, high fever (> 39°C / 102°F), non-productive cough, hyponatremia, diarrhea, and mental confusion. Incubation period is 2 to 10 days (up to 14 days). Case fatality rate is 10%-15% in community outbreaks and up to 25% in healthcare-acquired cases.
Pontiac Fever: Acute, self-limiting, non-pneumonic flu-like illness (fever, chills, myalgia, headache). High attack rate (> 90%), short incubation period (24-48 hours), with spontaneous complete recovery within 2-5 days without antibiotic therapy.
Thermal Proliferation Profile in Water Systems 0°C ──────────────── 20°C ──────────────── 35°C ──────── 46°C ──────── 50°C ─────── 60°C ─────── 70°C+
- [ Bacteria Dormant ] [ Slow Growth ] [ Optimal Amplification ] [ Survives ] [ Dies in ] [ Immediate ]
- [ No Multiplication ] [ 20°C - 35°C ] [ 35°C - 46°C ] [ 48°-50°C ] [ Minutes ] [ Death ]
< 20°C (< 68°F): Bacteria survive in a dormant state; negligible multiplication.
20°C - 50°C (68°F - 122°F): Active proliferation zone.
35°C - 46°C (95°F - 115°F): Optimal bacterial amplification zone inside protozoan hosts ( Acanthamoeba , Hartmannella ) within biofilm matrices.
≥ 50°C (≥ 122°F): Bacterial population slowly dies off.
≥ 60°C (≥ 140°F): 90% of bacteria killed within minutes.
≥ 70°C (≥ 158°F): Immediate thermal bactericidal destruction.
ASHRAE Standard 188 Water Management Programs (WMPs)
ASHRAE Standard 188 establishes minimum requirements for building water systems to control Legionella :
Hazard Analysis & Critical Control Points (HACCP): Identify amplification risks in cooling towers, evaporative condensers, whirlpool spas, decorative fountains, and complex potable plumbing networks.
Thermal Control Limits: Hot water storage tanks maintained at ≥ 60°C (140°F) ; secondary hot water distribution loops maintained at ≥ 50°C (122°F) at all return points. Point-of-use thermostatic anti-scald mixing valves installed close to fixtures.
Biocidal Disinfection: Free residual oxidant maintained throughout distribution (free chlorine 0.5-2.0 ppm, monochloramine, chlorine dioxide, or copper-silver ionization).
Remediation Protocols: Thermal shock flushing (distributing ≥ 71°C / 160°F water for 30 minutes to every fixture) or hyperchlorination (10-50 ppm free chlorine holding for 2 to 24 hours).
5. Endotoxins and Limulus Amebocyte Lysate (LAL) Testing
Endotoxins are complex lipopolysaccharide (LPS) macromolecules located in the outer membrane of Gram-negative bacteria (e.g., Pseudomonas , Enterobacter , Escherichia ). The active toxic moiety is Lipid A .
Occupational Exposure Scenarios & Toxicology
Key Industries: Agricultural grain elevators, animal confinement operations (swine/poultry barns), cotton and flax textile processing (associated with Byssinosis / "Monday morning chest tightness"), water-based metalworking fluids (MWFs), and wastewater treatment plants.
Toxic Action: Endotoxins are exceptionally heat-stable (surviving routine autoclaving). Inhaled endotoxin binds to CD14/TLR-4 receptors on alveolar macrophages, stimulating release of pro-inflammatory cytokines (IL-1, IL-6, TNF-α). This induces acute fever, airway bronchoconstriction, neutrophil recruitment, and acute drops in Forced Expiratory Volume in 1 Second (FEV1).
Sampling & The Limulus Amebocyte Lysate (LAL) Assay
Air Sampling: Collected on sterile, pyrogen-free glass fiber or PTFE filters in pyrogen-free cassettes. All analytical glassware must be depyrogenated at 250°C for ≥ 30 minutes .
LAL Assay Principle: Derived from the aqueous blood lysate of the horseshoe crab ( Limulus polyphemus ). Endotoxin activates a proenzyme clotting cascade in the lysate. The reaction is quantified using kinetic chromogenic (p-nitroaniline cleavage) or turbidimetric spectrophotometry.
Reporting Units: Endotoxin Units (EU) or nanograms (ng), where 1 ng ≈ 10 EU (standardized to USP Reference Endotoxin).
Exposure Guidelines: ACGIH guidance recommendation is 90 EU/m³ for total airborne endotoxin.
- 6. Worked Step-by-Step Calculation Examples
- Worked Example 6.3: Biosafety Cabinet Total Exhaust Volumetric Airflow
Problem: A biomedical containment laboratory utilizes a Class II Type B2 (Total Exhaust) biosafety cabinet with an effective work opening width of 4.0 ft (1.22 m) and a sash operating height of 8.0 inches (0.667 ft). Field anemometer measurements confirm an average inflow face velocity of 105 fpm. The internal downflow HEPA filter supplies 650 CFM of clean laminar air to the work surface, all of which is also drawn into the dedicated hard-ducted exhaust plenum. Calculate the total volumetric exhaust airflow (Qexhaust) required by the laboratory facility exhaust fan.
Solution Steps:
Calculate the sash face opening area (Aface): A face = Width × Height = 4.0 ft × ( 8.0 in 12 in/ft ) = 4.0 ft × 0.6667 ft = 2.667 ft 2 A_{\text{face}} = \text{Width} \times \text{Height} = 4.0\text{ ft} \times \left(\frac{8.0\text{ in}}{12\text{ in/ft}}\right) = 4.0\text{ ft} \times 0.6667\text{ ft} = 2.667\text{ ft}^2 A face = Width × Height = 4.0 ft × ( 12 in/ft 8.0 in ) = 4.0 ft × 0.6667 ft = 2.667 ft 2
Calculate the volumetric inflow rate (Qinflow): Q inflow = A face × V face = 2.667 ft 2 × 105 ft/min = 280.0 CFM Q_{\text{inflow}} = A_{\text{face}} \times V_{\text{face}} = 2.667\text{ ft}^2 \times 105\text{ ft/min} = 280.0\text{ CFM} Q inflow = A face × V face = 2.667 ft 2 × 105 ft/min = 280.0 CFM
Calculate total exhaust airflow (Qexhaust) for a Class II Type B2 cabinet: Because Type B2 recirculates 0% of the air, the dedicated facility exhaust must extract both the inflow air and the internal supply downflow air: Q exhaust = Q inflow + Q downflow = 280.0 CFM + 650.0 CFM = 930.0 CFM Q_{\text{exhaust}} = Q_{\text{inflow}} + Q_{\text{downflow}} = 280.0\text{ CFM} + 650.0\text{ CFM} = 930.0\text{ CFM} Q exhaust = Q inflow + Q downflow = 280.0 CFM + 650.0 CFM = 930.0 CFM
Result: The building exhaust system must maintain a minimum dedicated exhaust flow of 930 CFM .
Worked Example 6.4: Airborne Endotoxin Exposure Assessment
Problem: An industrial hygienist collects a personal air sample on a grain elevator worker handling corn silage. A sterile, pyrogen-free glass fiber filter is operated at a flow rate of 2.0 L/min for a full 8-hour shift (480 minutes). The analytical laboratory performs a kinetic chromogenic LAL assay and reports a total endotoxin loading of 11,520 EU on the filter (blank-corrected).
Calculate the sampled air volume in cubic meters (m³).
Calculate the 8-hour Time-Weighted Average (TWA) endotoxin concentration in EU/m³.
Evaluate compliance against the ACGIH health-based guidance value (90 EU/m³).
Solution Steps:
Calculate total air volume (V): V = Q × t = 2.0 L/min × 480 min = 960 Liters = 0.960 m 3 V = Q \times t = 2.0\text{ L/min} \times 480\text{ min} = 960\text{ Liters} = 0.960\text{ m}^3 V = Q × t = 2.0 L/min × 480 min = 960 Liters = 0.960 m 3
Calculate airborne endotoxin concentration (C): C = Total Endotoxin Loading Volume in m 3 = 11 , 520 EU 0.960 m 3 = 12 , 000 EU/m 3 C = \frac{\text{Total Endotoxin Loading}}{\text{Volume in m}^3} = \frac{11,520\text{ EU}}{0.960\text{ m}^3} = 12,000\text{ EU/m}^3 C = Volume in m 3 Total Endotoxin Loading = 0.960 m 3 11 , 520 EU = 12 , 000 EU/m 3
Evaluate against ACGIH Guidance Threshold: C Guidance Value = 12 , 000 EU/m 3 90 EU/m 3 = 133.3 \frac{C}{\text{Guidance Value}} = \frac{12,000\text{ EU/m}^3}{90\text{ EU/m}^3} = 133.3 Guidance Value C = 90 EU/m 3 12 , 000 EU/m 3 = 133.3
Result: The worker's exposure is 12,000 EU/m³ , which is 133 times the ACGIH guidance limit , indicating an extreme risk of acute non-allergic airway inflammation and organic dust toxic syndrome (ODTS).